|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|
| Revenues: | ||||
| Net premiums written (1) | ||||
| Escrow, other title-related fees and other | ||||
| Investment, dividend and other income | ||||
| Total revenues | ||||
| Expenses: | ||||
| Insurance Commissions | ||||
| Title examination expense | ||||
| Provision for claims | ||||
| Personnel costs | ||||
| Other operating expenses | ||||
| Goodwill impairment | ||||
| Long-lived asset impairment | ||||
| Total operating expenses | ||||
| Operating loss from continuing operations | ||||
| Other (expense) income: | ||||
| Change in fair value of Warrant and Sponsor Covered Shares liabilities | ||||
| Interest expense | ||||
| Loss from continuing operations before income taxes | ||||
| Income tax benefit (expense) | ||||
| Loss from continuing operations, net of taxes | ||||
| Loss from discontinued operations, net of taxes | ||||
| Net loss | ||||
| Earnings per share: | ||||
| Net loss from continuing operations per share attributable to stockholders - basic and diluted (in dollars per share) | ||||
| Net loss per share attributable to stockholders - basic and diluted (in dollars per share) | ||||
| Net loss per share attributable to stockholders - diluted (in usd per share) | ||||
| Weighted average shares outstanding common stock - basic and diluted (in shares) | ||||
Loading...